{"transactions":[{"id":1368583,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2024-11-12T16:59:43.000Z","date":"2024-11-11","kind":"purchase","planned":false,"acquired":true,"shares":175000,"price":5.64,"value":987000.0,"ownership":{"direct":false,"nature":"Through The Hull Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.52 to $5.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":175000,"source":{"system":"sec-edgar","filing":"0001823239-24-000113","document":"wk-form4_1731448774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323924000113/wk-form4_1731448774.xml","form_type":"4"}},{"id":1572125,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2024-03-18T17:54:24.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":17560,"price":7.7,"value":135212.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":267072,"source":{"system":"sec-edgar","filing":"0001823239-24-000034","document":"wk-form4_1710798854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323924000034/wk-form4_1710798854.xml","form_type":"4"}},{"id":1633120,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2024-02-20T18:46:40.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":10729,"price":5.48,"value":58794.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":284632,"source":{"system":"sec-edgar","filing":"0001823239-24-000023","document":"wk-form4_1708472789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323924000023/wk-form4_1708472789.xml","form_type":"4"}},{"id":1676145,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2024-01-18T18:23:32.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":75842,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded  under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":295361,"source":{"system":"sec-edgar","filing":"0001823239-24-000008","document":"wk-form4_1705620203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323924000008/wk-form4_1705620203.xml","form_type":"4"}},{"id":1946417,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-17T16:51:35.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":270109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on April 15, 2023 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":270109,"derivative":{"exercise_price":15.52,"expiration_date":"2033-03-15","underlying":"Class A Common Stock","underlying_shares":270109},"source":{"system":"sec-edgar","filing":"0001823239-23-000026","document":"wf-form4_167908626696366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323923000026/wf-form4_167908626696366.xml","form_type":"4"}},{"id":1946416,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-17T16:51:35.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":147638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded  under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of March 15, 2024, March 15, 2025, and March 15, 2026, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":219519,"source":{"system":"sec-edgar","filing":"0001823239-23-000026","document":"wf-form4_167908626696366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323923000026/wf-form4_167908626696366.xml","form_type":"4"}},{"id":2007023,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T16:33:30.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":9719,"price":15.23,"value":148020.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":71881,"source":{"system":"sec-edgar","filing":"0001823239-23-000008","document":"wf-form4_167666958156029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000182323923000008/wf-form4_167666958156029.xml","form_type":"4"}},{"id":2249253,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2022-06-01T16:00:41.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":41172,"ownership":{"direct":false,"nature":"By Hull Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 22, 2021, by and among Coronado Topco, Inc. (\"Coronado Topco\"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the \"Effective Time\"). At the Effective Time: (a) each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash; and (b) each restricted stock unit, whether vested or unvested, was converted into a Coronado Topco equity right of the same type and on the same terms and conditions as were applicable to the corresponding restricted stock unit immediately prior to the Effective Time, which right shall be settled in cash upon vesting."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-033124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000120919122033124/doc4.xml","form_type":"4"}},{"id":2249252,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2022-06-01T16:00:41.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":21011,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 22, 2021, by and among Coronado Topco, Inc. (\"Coronado Topco\"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the \"Effective Time\"). At the Effective Time: (a) each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash; and (b) each restricted stock unit, whether vested or unvested, was converted into a Coronado Topco equity right of the same type and on the same terms and conditions as were applicable to the corresponding restricted stock unit immediately prior to the Effective Time, which right shall be settled in cash upon vesting."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-033124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000120919122033124/doc4.xml","form_type":"4"}},{"id":2423883,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-01-27T16:00:19.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":151200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":151200,"derivative":{"exercise_price":26.32,"expiration_date":"2032-01-25","underlying":"Class A Common Stock","underlying_shares":151200},"source":{"system":"sec-edgar","filing":"0000899243-22-003415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000089924322003415/doc4.xml","form_type":"4"}},{"id":2423882,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-27T16:00:19.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":81600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":81600,"source":{"system":"sec-edgar","filing":"0000899243-22-003415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000089924322003415/doc4.xml","form_type":"4"}},{"id":2726826,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-05T17:00:51.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest in eight equal quarterly installments beginning on June 30, 2021."}],"balance_after":21011,"source":{"system":"sec-edgar","filing":"0001209191-21-030376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000120919121030376/doc4.xml","form_type":"4"}},{"id":2963969,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2020-11-30T16:34:32.000Z","date":"2020-11-25","kind":"purchase","acquired":true,"shares":35000,"price":26.94,"value":942900.0,"ownership":{"direct":false,"nature":"Through Glossatori, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.81 to $27.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000899243-20-032306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000089924320032306/doc4.xml","form_type":"4"}},{"id":2969651,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":86160,"kind":"person","name":"HULL CARL","position":1,"cik":"0001205465","reported_name":"HULL CARL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-11-23T17:33:37.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":27,"expiration_date":"2030-11-19","underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-031948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205465/000089924320031948/doc4.xml","form_type":"4"}}]}